The Usage of Type 2 Diabetes Medication for Outpatients at the Ministry of Public Security Traditional Medicine Hospital

Abstract

This study aimes to analyse the usage of type 2 diabetes medication for outpatients at the Ministry of Public Security Traditional Medicine Hospital and to rate their adherence to the treatment. In this study, Type 2 diabetic patients were treated as outpatients and managed for at least 12 months at the clinic of the hospital. The results show that after 12 months of treatment, the average fasting blood glucose value decreased from 7.6 ± 1.76 mmol/l to 7.42 ± 1.81 mmol/l and the percentage of the patients either with blood glucose changes or reached the FPG target, increased from 38.3% to 70.0%, a statistically significant difference with p <0.05. After 6 months of treatment from the time of T_-6 to T₀, HbA1c index decreased by 7.1 ± 1.0 to 6.4 ± 0.9% and the percentage of the patients either with HbA1C value changes or achieved the target, increased from 50.0% to 75.0%. The percentage of the patients who had good compliance was 60.8%. With an additional drug in the regimen, the adherence reduced by 29% (OR = 0.71; 95% CI 0.56 - 0.89; p = 0.002). The adherence of the 1-year-older patients decreased by 9% (OR = 0.91; 95% CI 0.84 - 0.97; p = 0.03). The study concludes that most of the patients received stable treatment; the regimens promoted maximum therapeutic effect. The two factors affecting the level of compliance of the patients with the drug were the age and the number of diabetes medicines used in the application.

Keywords

Type 2 diabetes, adherence to treatment, outpatients.

References

[1] Association. American Diabetes, Standards of medical care in diabetes - 2018, https://diabetesed.net/wp-content/uploads/2017/12/2018-ADA-Standards-of-Care.pdf, 2018 (accessed 25 May 2019).
[2] A. Jafarian-Amirkhizi, A. Sarayani, K. Gholami, M. Taghizadeh-Ghehi, K. Heidari, A. Jafarzadeh-Kohneloo, D.E.Morisky, Adherence to medications, self-care activity, and HbA1c status among patients with type 2 diabetes living in an urban area of Iran, J Diabetes Metab Disord. 17(2) (2018) 165-172. https://doi: 10.1007/s40200-018-0356-4.
[3] D.E. Morisky, M.R. Di Matteo, Improving the measurement of self-reported medication nonadherence: Response to Authors, J Clin Epidemiol. 64(3) (2011) 255-257; discussion 258-63. https:// doi: 10.1016/j.jclinepi.2010.09.002.
[4] Y. Tominaga, T. Aomori, T. Hayakawa, D.E. Morisky, K. Takahashi, M. Mochizuki, Relationship between medication adherence and glycemic control in Japanese patients with type 2 diabetes. Pharmazie. 73(10) (2018) 609-612. https://doi: 10.1691/ph.2018.8587.
[5] M.C. Govern Andrew, T. Zayd, Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol, BMJ Open, 6(2) (2016) e010469. https://doi: https://doi: 10.1136/bmjopen-2015-010469.
[6] M. Tiktin, S. Celik, Understanding adherence to medications in type 2 diabetes care and clinical trials to overcome barriers: a narrative review, Curr Med Res Opin. 32(2) (2016) 277-287. https:// doi: https:// doi: 10.1185/03007995.2015.1119677.